“…This study sought to estimate the proportion of admissions among CAP patients who received ceftriaxone and macrolide therapy, one of the most commonly prescribed guideline-concordant CAP regimens, by PSI risk class and Charlson comorbidity index (CCI) score. (2) Methods: A retrospective cross-sectional study of patients in the Vizient(®) (MedAssets, Irving, Texas) database between 2012 and 2015 was performed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso